They may not be the optimal agents for prevention of the direct cardiotoxic effects of anthracyclines, given that there may not be significant neurohormonal activation.
← all excerpts
Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: <i>JACC: CardioOncology</i> Primer.
1
—
—